MAPT Gene Dementia Frontotemporal Genetic Test
Welcome to DNA Labs UAE, where we offer the MAPT Gene Dementia Frontotemporal Genetic Test. This test is designed to analyze the MAPT gene, which codes for the tau protein and plays a crucial role in the structure and function of neurons in the brain.
Test Details
Frontotemporal dementia (FTD) is a group of disorders that affect the frontal and temporal lobes of the brain. Mutations in the MAPT gene have been linked to FTD and other neurodegenerative disorders. Our NGS (next-generation sequencing) genetic testing method allows for a comprehensive analysis of an individual’s genetic makeup, including the identification of mutations in genes like MAPT that may increase the risk of developing FTD.
Test Components and Price
The MAPT Gene Dementia Frontotemporal Genetic Test is priced at 4400.0 AED. The test can be performed using blood or extracted DNA samples, or even just one drop of blood on an FTA card.
Sample Condition
We accept blood samples, extracted DNA samples, or one drop of blood on an FTA card for this test.
Report Delivery
Once the sample is received, the report will be delivered within 3 to 4 weeks.
Test Type
This test falls under the category of neurological disorders.
Referring Doctor
Our neurologist will oversee the MAPT Gene Dementia Frontotemporal Genetic Test.
Test Department
The test will be conducted in our Genetics department.
Pre Test Information
Prior to undergoing the MAPT Gene Dementia Frontotemporal Genetic Test, it is important to provide the clinical history of the patient. Additionally, a genetic counseling session will be conducted to draw a pedigree chart of family members affected by MAPT Gene Dementia Frontotemporal.
Important Considerations
It is crucial to note that genetic testing for dementia is not a definitive diagnostic tool. It should be used in conjunction with other clinical and diagnostic tests. Genetic testing can also have emotional and psychological implications, so it is important for individuals to carefully consider the potential risks and benefits before undergoing testing.
| Test Name | MAPT Gene Dementia frontotemporal Genetic Test |
|---|---|
| Components | |
| Price | 4400.0 AED |
| Sample Condition | Blood or Extracted DNA or One drop Blood on FTA Card o |
| Report Delivery | 3 to 4 Weeks |
| Method | NGS Technology |
| Test type | Neurological Disorders |
| Doctor | Neurologist |
| Test Department: | Genetics |
| Pre Test Information | Clinical History of Patient who is going for MAPT Gene Dementia, frontotemporal NGS Genetic DNA Test A Genetic Counselling session to draw a pedigree chart of family members affected with MAPT Gene Dementia, frontotemporal |
| Test Details |
The MAPT gene is a gene that codes for the tau protein, which plays a role in the structure and function of neurons in the brain. Mutations in this gene have been linked to several neurodegenerative disorders, including frontotemporal dementia (FTD), a group of disorders that affect the frontal and temporal lobes of the brain. NGS (next-generation sequencing) genetic testing is a type of genetic testing that can analyze multiple genes at once, allowing for a more comprehensive analysis of an individual’s genetic makeup. In the context of dementia, NGS genetic testing can help identify mutations in genes like MAPT that may increase an individual’s risk of developing FTD. However, it’s important to note that genetic testing for dementia is not a definitive diagnostic tool and should be used in conjunction with other clinical and diagnostic tests. Additionally, genetic testing can have emotional and psychological implications, and individuals should consider the potential risks and benefits before undergoing testing. |
